A 3-year-old child with Kawasaki disease is in the acute phase and has been receiving intravenous immunoglobulin (IVIG) and high-dose aspirin therapy. The child's temperature is 102.8°F (39.3°C), and the parents are concerned about the persistent fever. What is the most appropriate nursing intervention at this time?

In Kawasaki disease, fever may persist despite IVIG and aspirin therapy, so continuing treatment while monitoring for coronary artery complications is appropriate. Other options like administering acetaminophen or increasing aspirin dosage are not indicated without specific orders.

Clinical Context and Pathophysiology

Kawasaki disease (KD) is an acute, self-limited systemic vasculitis that predominantly affects children under 5 years of age. The primary concern during the acute phase is the development of coronary artery abnormalities (CAAs), including dilation and aneurysms, which can lead to significant acquired heart disease ^[4]. The acute phase is characterized by high fevers and systemic inflammation driven by a dysregulated immune response ^[4]. The standard first-line therapy is a combination of intravenous immunoglobulin (IVIG) and high-dose acetylsalicylic acid (aspirin). IVIG works by modulating the inflammatory cascade, while aspirin provides both anti-inflammatory effects at high doses and antiplatelet effects at low doses ^[4].

Interpreting the Patient's Status

The child’s persistent fever of 102.8°F (39.3°C) after the initiation of IVIG and aspirin therapy is a critical clinical finding. However, it is essential to understand that the therapeutic effect of IVIG is not immediate. The primary goal of treatment is to reduce inflammation and, most importantly, to prevent coronary artery complications. A fever can persist for 24 to 48 hours after IVIG completion, and its presence alone does not immediately signify treatment failure ^[4]. The concept of IVIG resistance is a major clinical dilemma, but it is typically defined as persistent or recrudescent fever at least 36 hours after the end of the IVIG infusion, not during or immediately after administration . Therefore, a fever at this point requires vigilant monitoring rather than an abrupt change in the treatment plan.

Rationale for the Correct Answer (Option 2)

The most appropriate nursing intervention is to continue the current treatment and monitor closely for signs of coronary artery complications. The core of acute-phase management is vigilant surveillance for cardiovascular involvement, as coronary artery lesions are the most serious complication ^[4]. The nurse’s priority is to perform serial clinical assessments, including monitoring vital signs, auscultating for a gallop rhythm or murmur, and observing for signs of myocarditis or pericarditis. This clinical monitoring is supported by laboratory and echocardiographic findings, which are central to predicting and detecting coronary artery dilation . The development of a nomogram prediction model for coronary artery lesions highlights the importance of integrating multiple clinical and laboratory parameters over time to assess risk, rather than reacting to a single data point like a persistent fever .

Why Other Options Are Incorrect

- Option 1: Administer acetaminophen to reduce the fever immediately. This is not recommended. While acetaminophen is an antipyretic, its use during the acute phase of KD, especially with high-dose aspirin, can mask the fever curve. The fever pattern is a crucial clinical indicator used to determine the effectiveness of IVIG therapy and to diagnose IVIG resistance [3,4]. Masking the fever could delay the recognition of true treatment failure and the need for rescue therapy, thereby increasing the risk of silent coronary artery damage.

- Option 3: Increase the aspirin dosage to achieve better anti-inflammatory effects. This is inappropriate. The child is already on high-dose aspirin (30-50 mg/kg/day) for its anti-inflammatory effect during the acute phase ^[4]. Increasing the dose further would not provide additional anti-inflammatory benefit and would significantly elevate the risk of salicylate toxicity and Reye's syndrome. The dose is only transitioned to a low antiplatelet dose after the child has been afebrile for 48-72 hours ^[4].

- Option 4: Prepare for immediate cardiac catheterization due to treatment failure. This is a premature and overly invasive step. A persistent fever at this stage does not constitute confirmed treatment failure, nor is it an indication for immediate cardiac catheterization. Cardiac catheterization is a diagnostic and sometimes interventional tool reserved for evaluating known coronary artery pathology, such as significant aneurysms or stenosis, not for the initial management of a fever in the acute phase . The first-line assessment for coronary arteries is serial echocardiography.